Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-01-07

FDA Approved: LEVULAN KERASTICK — Supplemental Application (Sun Pharmaceutical Industries, Inc)

View source ↗

Summary

FDA approved a supplemental application for LEVULAN KERASTICK (aminolevulinic acid hydrochloride) from Sun Pharmaceutical Industries, expanding its labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVULAN KERASTICK (AMINOLEVULINIC ACID HYDROCHLORIDE)

Snippet

SUPPL AP for LEVULAN KERASTICK (AMINOLEVULINIC ACID HYDROCHLORIDE)